Keita Funakawa
Keita Funakawa is co-founder and COO of Nanome Inc., a technology company enabling scientists, students, and hobbyists to design and simulate molecules in Virtual Reality. Nanome is the next step in computational/medicinal chemistry, structural biology, and beyond. Nanome has helped researchers in the global fight against Covid-19 around the globe in the USA, Canada, Italy, Switzerland, China, and Australia.